123 episodes

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

e-ESO Podcasts ESO - European School of Oncology

    • Education

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

    From clinical and academic culture in radiation oncology - how to cross the chasm?

    From clinical and academic culture in radiation oncology - how to cross the chasm?

    Expert: Vincent Grégoire, Centre Léon Bérard, Lyon, FR

    • 15 min
    Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

    Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

    Expert: Radwa Hamed Sabra, Lecturer of Clinical Oncology, Armed Forces College of Medicine Egypt, Cairo, Egypt

    • 5 min
    Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

    Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

    Experts:

    Paula Fidalgo, Centro Hospitalar Universitário de Santo António, Porto, PT

    João Coelho, Centro Hospitalar Universitário de Santo António, Porto, PT

    • 11 min
    Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

    Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

    Expert: Panagiotis J. Vlachostergios, Weill Cornell Medicine, New York, NY, USA

    • 2 min
    The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

    The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

    Expert: Franco Cavalli, Foundation for the Institute for Oncology Research (IOR), Bellinzona, Switzerland

    • 10 min
    Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

    Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

    Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil

    • 5 min

Top Podcasts In Education

The Mel Robbins Podcast
Mel Robbins
The Jordan B. Peterson Podcast
Dr. Jordan B. Peterson
Digital Social Hour
Sean Kelly
The Rich Roll Podcast
Rich Roll
Mick Unplugged
Mick Hunt
TED Talks Daily
TED

You Might Also Like